Intelligence

Vascular endothelial growth factor A
#Drug targets #Gilead Sciences #GlobalData #Krystal Biotech #Neurodegenerative disorders #Regenerative Medicine

Regenerative medicine switches to VEGF as top drug target

Regenerative medicines in early-stage development have seen a change in drug targets compared to therapies in late-stage development. According to analysts GlobalData, early-stage therapies are now focused on vascular endothelial growth factor (VEGF) as the top drug target, with three drugs currently in development. Surprisingly, the… Read More

#News #Trends & Analysis

#Drug development #Drug discovery #Imaging #Thermo Fisher Scientific

Imaging protocol handbook

This guide will provide you with: A quick and easy way to find the most used and trusted protocols for imaging A go‑to resource for reliable methods Step‑by‑step methods to enable your imaging success… Read More

#Resources

#AI / data analytics / healthtech / informatics #Dotmatics #Drug development #Drug discovery #Electronic Lab Notebooks (ELN)

Electronic lab notebook buyer’s guide & checklist

You’re in R&D, so you know the key to success is mastering your workflow. With so many different tasks to keep track of, it’s easy to feel overwhelmed and bogged down by manual data entry, paper-based processes, and transcription errors. You’ve heard of ELNs, but you may be unfamiliar with… Read More

#Resources

Diversity
#Clinical trial design #Clinical trials #Diversity #Inato #Inclusivity #Investment #Oncology

$20 million in new funding to make clinical trials more inclusive

Clinical trial technology platform Inato, based in Paris, France, has closed a $20 million Series A funding from investors including Cathay Innovation, Obvious Ventures, La Maison and Top Harvest Capital. With the new funding, Inato will advance its diversity product offering to meet the new FDA… Read More

#Business & Investment #News #Start-up Zone

ACROBiosystems DDW white paper
#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #GMP

Diving deep into cell therapy: An industry perspective

Cell therapy research has never been more exciting with all of the research ongoing. Learn more about the trends, insights, and perspectives from ACROBiosystems as a manufacturer of cell therapy reagents, including topics like: CAR-NK research Developing new CAR constructs Evaluation CAR expression detection Role of GMP Manufacturing in cell… Read More

#Resources

#Data #Drug development #Gene sequencing #Genome sequencing #Genomics #Healthcare #Precision medicine #Trusted research environment

Why Trusted Research Environments are key to the future of genomics  

Genomics is driving a revolution in drug development and, in the long run, the state of public healthcare. Advances in sequencing are leading to scientific breakthroughs in preventative care, faster diagnoses, and proactive medical interventions. Jack Dix, Head of Healthcare Strategy and Consulting at Kainos, expands.  Genetic… Read More

#Exclusive Content #Opinion #Trends & Analysis

Global cancer research eBook
#Breast cancer #Cancer research #Cancer treatment #Drug development #Drug discovery #Oncology

Global cancer research: Where are the breakthroughs?

This latest eBook sponsored by Sino Biological features insight on how the global drug discovery and development sector is making breakthroughs in cancer research.  Download this exclusive eBook to learn more about:  The global developments tackling the burden of cancer   Advances and challenges… Read More

#DDW eBooks #Intelligence

#Drug development #Drug discovery #Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines

Riding the mRNA highway: development, manufacturing, and beyond

Download this eBook to learn more about process development and manufacturing in the mRNA space to enable successful scale-ups of mRNA production for therapeutic applications. Topics covered in the eBook include: Expert views on mRNA development and manufacturing Advantages of mRNA processes compared to traditional vaccine manufacturing Best practices for… Read More

#Resources

Imaging eBook
#Drug development #Drug discovery #Imaging #Magnetic Resonance Imaging (MRI) #Pharmaceuticals #Technology

Imaging and drug discovery: Applications and innovations

This latest eBook sponsored by Bethyl Laboratories/Fortis Life Science features expert opinions on how imaging technologies are informing drug discovery and bringing more insight into treating diseases. Download this exclusive eBook to learn more about: The importance of imaging innovations in the fight against cancer How magnetic resonance imaging (MRI)… Read More

#DDW eBooks #Intelligence

#AI #Biobanking #Drug discovery #Genomics #Personalised medicine

Drug discovery hotspots: Focus on Qatar

DDW Editor Reece Armstrong takes a look at Qatar’s drug discovery and life sciences market, exploring how the country is utilising innovative technologies in its approach to healthcare.   The Middle East represents one of the world’s most lucrative markets for pharmaceuticals. Along with Africa, the Middle East stands as… Read More

#Exclusive Content #Market Reports

Start-up business
#BioInnovation Institute #Drug discovery #Investment #Life sciences #Start-ups

Institiute gives a boost to five new life science start-ups

Five drug discovery companies have entered the BioInnovation Institute’s (BII) Venture Lab acceleration programme for early-stage companies as part of a cohort of ten new members.  The 12-month Venture Lab programme is designed to support start-up companies with business acceleration, scientific, and team development, and provides a… Read More

#News #Start-up Zone

Senior couple jogging
#Age-related diseases (ARDs) #Five Alarm Bio #Investment #Seed funding #Start-ups

Anti-ageing therapeutics company completes seed funding

Five Alarm Bio (FAB) has completed a seed investment round, raising over £500K ($605K). The funding will drive proprietary research into novel compounds that extend healthy lifespan of cells and tissues, with therapeutic potential across a broad range of age-related diseases. Investors include Cambridge Angels, Meltwind, o2h Ventures, and SyndicateRoom,… Read More

#News #Start-up Zone

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Atomic AI #Molecular Biology #RNA #Turning Science into Business

Turning science into business: Merging AI and RNA

New kids on the block, Atomic AI, recently closed a $35 million series A financing. DDW’s Diana Spencer speaks to Raphael Townshend PhD, Founder and CEO of Atomic AI, about the company’s successes so far, plans for the future and the unique approach of combining RNA structural biology and AI… Read More

#Exclusive Content #Start-up Zone

Researcher pipetting samples in microplate
#Drug delivery #Funding #Genetics #Genetics / genomics #Investment #Start-ups

Start-up aims to advance transformative genetic medicines

Aera Therapeutics has launched with a vision to “unlock the potential of genetic medicines across a wide range of modalities and therapeutic areas”.   The company’s delivery platform is based on research conducted in the laboratory of scientific founder Feng Zhang and aims to address the limitations of… Read More

#News #Start-up Zone

Scandinavia
#Drug development #Drug discovery #Life sciences #Market reporting #Scandinavia #Sweden

Scandinavia: insight into opportunities for drug discovery

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. Though not without its challenges, the life sciences industry in Scandinavia… Read More

#Exclusive Content #Market Reports